• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织学作为早期宫颈癌的预后因素。三级医疗机构的经验。

Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.

作者信息

Barquet-Muñoz Salim Abraham, Cruz-Rodríguez Efraín, Cantú De León David Francisco, Isla-Ortiz David, Montalvo-Esquivel Gonzalo, Herrera-Montalvo Luis Alonso, Pérez-Plasencia Carlos, Pérez-Montiel Delia, Herrera-Gómez Ángel

机构信息

Department of Gynecologic Oncology, Instituto Nacional de Cancerología, Mexico City, Mexicoo.

出版信息

Rev Invest Clin. 2017 Sep-Oct;69(5):286-292. doi: 10.24875/ric.17002143.

DOI:10.24875/ric.17002143
PMID:29077701
Abstract

BACKGROUND

Cervical carcinoma (CC) is one of the most frequent neoplasms, especially in developing countries. The most common histopathological type is squamous cell carcinoma (SCC), followed by adenocarcinoma (AC) and adenosquamous carcinoma (ASC). Prognosis according to histological type is controversial.

OBJECTIVE

The objective of this study is to describe and compare the prognoses of the most common histologies of CC in the early stages.

MATERIALS AND METHODS

We reviewed records of patients attended at the Instituto Nacional de Cancerología of Mexico with CC surgically treated Stages IA2-IB1 and IIA1, including the histological types SCC, AC, and ASC. Patients who had another malignant neoplasm, cervical cancer in situ, locally advanced neoplasm, and metastatic neoplasm were excluded from the study. A descriptive and comparative analysis was conducted. Overall survival (OS) and disease-free period were calculated for each histological type with the Kaplan-Meier method and were compared with the log-rank test.

RESULTS

A total of 202 records were obtained, of which 131 (64.9%) had SCC, 57 (28.2%) AC, and 14 (6.9%) ASC. The 5-year DFS was 94.4% for SCC, 98.1% for AC, and 92.3% for ASC, without a statistically significant difference (p = 0.55). The 5-year OS for SCC was 97.9%, for AC was 97.8%, and for ASC was 100%, without a statistically significant difference (p = 0.702).

CONCLUSIONS

DFS and OS did not differ between the most common histological types of CC at the early stages.

摘要

背景

宫颈癌(CC)是最常见的肿瘤之一,尤其是在发展中国家。最常见的组织病理学类型是鳞状细胞癌(SCC),其次是腺癌(AC)和腺鳞癌(ASC)。根据组织学类型判断的预后存在争议。

目的

本研究的目的是描述和比较早期CC最常见组织学类型的预后。

材料与方法

我们回顾了在墨西哥国家癌症研究所接受手术治疗的IA2 - IB1期和IIA1期CC患者的记录,包括组织学类型SCC、AC和ASC。患有其他恶性肿瘤、宫颈原位癌、局部晚期肿瘤和转移性肿瘤的患者被排除在研究之外。进行了描述性和对比性分析。采用Kaplan - Meier方法计算每种组织学类型的总生存期(OS)和无病生存期,并通过对数秩检验进行比较。

结果

共获得202份记录,其中131例(64.9%)为SCC,57例(28.2%)为AC,14例(6.9%)为ASC。SCC的5年无病生存率为94.4%,AC为98.1%,ASC为92.3%,差异无统计学意义(p = 0.55)。SCC的5年总生存率为97.9%,AC为97.8%,ASC为100%,差异无统计学意义(p = 0.702)。

结论

早期CC最常见组织学类型之间的无病生存期和总生存期无差异。

相似文献

1
Histology as Prognostic Factor in Early-Stage Cervical Carcinoma. Experience in a Third-Level Institution.组织学作为早期宫颈癌的预后因素。三级医疗机构的经验。
Rev Invest Clin. 2017 Sep-Oct;69(5):286-292. doi: 10.24875/ric.17002143.
2
Treatment outcomes of locally advanced cervical cancer by histopathological types in a single institution: A propensity score matching study.单中心研究:不同组织学类型局部晚期宫颈癌的治疗结局:倾向评分匹配研究。
J Formos Med Assoc. 2018 Oct;117(10):922-931. doi: 10.1016/j.jfma.2018.07.002. Epub 2018 Jul 17.
3
Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.组织学亚型对接受根治性放疗的局部晚期宫颈癌患者生存的影响:腺癌/腺鳞癌与鳞状细胞癌的比较。
J Gynecol Oncol. 2017 Mar;28(2):e19. doi: 10.3802/jgo.2017.28.e19. Epub 2016 Dec 8.
4
Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.局部晚期腺癌/腺鳞癌与宫颈鳞癌根治性放疗的临床特征、疗效及预后差异。
Acta Obstet Gynecol Scand. 2014 Jul;93(7):661-8. doi: 10.1111/aogs.12383. Epub 2014 Apr 22.
5
Comparison of the prognoses of FIGO stage I to stage II adenosquamous carcinoma and adenocarcinoma of the uterine cervix treated with radical hysterectomy.比较 FIGO 分期 I 期至 II 期宫颈腺鳞癌和腺癌患者接受根治性子宫切除术的预后。
Int J Gynecol Cancer. 2012 Oct;22(8):1389-97. doi: 10.1097/IGC.0b013e31826b5d9b.
6
Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.根治性子宫切除术及辅助放疗或放化疗治疗宫颈腺癌或腺鳞癌的临床行为和结局。
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):420-7. doi: 10.1016/j.ijrobp.2011.12.013. Epub 2012 Feb 24.
7
Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.腺鳞组织学特征预示晚期宫颈癌患者预后不良,但早期宫颈癌患者并非如此。
Cancer. 2003 May 1;97(9):2196-202. doi: 10.1002/cncr.11371.
8
Comparison of adenocarcinoma and adenosquamous carcinoma prognoses in Chinese patients with FIGO stage IB-IIA cervical cancer following radical surgery.比较 FIGO 分期 IB-IIA 期宫颈癌根治术后中国患者腺癌和腺鳞癌的预后。
BMC Cancer. 2020 Jul 16;20(1):664. doi: 10.1186/s12885-020-07148-x.
9
Initial treatment for FIGO 2018 stage IIIC cervical cancer based on histological type: A 14-year multicenter study.基于组织学类型的 2018 年 FIGO 分期 IIIC 期宫颈癌的初始治疗:一项 14 年多中心研究。
Cancer Med. 2023 Oct;12(19):19617-19632. doi: 10.1002/cam4.6586. Epub 2023 Sep 28.
10
The prognostic impact of histological type on clinical outcomes of early-stage cervical cancer patients whom have been treated with radical surgery.组织学类型对接受根治性手术治疗的早期宫颈癌患者临床结局的预后影响。
J Obstet Gynaecol. 2017 Apr;37(3):347-354. doi: 10.1080/01443615.2016.1245279. Epub 2017 Jan 31.

引用本文的文献

1
Immunohistochemical profiling of Bcl-2 and EGFR proteins in cervical carcinoma at a tertiary hospital in Ghana.加纳一家三级医院宫颈癌中Bcl-2和表皮生长因子受体(EGFR)蛋白的免疫组织化学分析
Niger Med J. 2025 Jun 16;66(2):575-585. doi: 10.71480/nmj.v66i2.713. eCollection 2025 Mar-Apr.
2
The best postoperative adjuvant therapy for patients with early stage cervical adenosquamous carcinoma.早期宫颈腺鳞癌患者的最佳术后辅助治疗。
BMC Womens Health. 2022 Apr 12;22(1):112. doi: 10.1186/s12905-021-01588-8.
3
Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.
影响宫颈癌患者总生存和无事件生存的临床病理因素的预后意义:系统评价和荟萃分析。
Med Sci Monit. 2022 Mar 9;28:e934588. doi: 10.12659/MSM.934588.